公司资料
GeoVax Labs 股价、新闻与催化剂
- 股票代码:
- GOVX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.66 USD (-8.77%)
收盘价
最后更新: 2026年8月17日
10.9M USD
市值
股价为何变动
As of Aug 17, 2026, GOVX closed down 8.77% at $0.6550. No new same-company headline was identified in the current news window.
公司概览
业务概览
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform. Its story is built around infectious disease and oncology programs that seek to create targeted immune responses.
所在地与行业分类
GeoVax is headquartered in the United States and listed on NASDAQ. It sits in small-cap vaccine and immunotherapy biotechnology.
商业模式特征
The company depends on clinical and preclinical progress, partner interest, and capital efficiency to advance its platform. Investors watch vaccine updates, oncology programs, and whether the platform can produce differentiated immune responses.
生物医药行业定位
GeoVax occupies a niche vaccine-and-immunotherapy position within biotech. It is a catalyst-driven small-cap name where platform validation matters more than commercial scale.
未来催化剂
- GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant. The company still needs human proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。